Drug class profile · refreshed daily from federal data

NSAID (Nonsteroidal Anti-Inflammatory Drug)

1 molecule in this class, $54.0M combined CY2024 Part D spend across 2.6M claims. Class-level guide below for benefits decision-makers: where the money lives, where the savings live.

Last updated 14 Jul 2026

NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annualOrange Book: weeklyShortages: daily

Class summary at a glance.

Every drug in the NSAID (Nonsteroidal Anti-Inflammatory Drug) class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 1tracked in Part D
CY24 Part D spend: $54.0Mcombined across class
Total Rx claims: 2.6M1.6M unique beneficiaries
Generic mfrs (active): 21across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Ketorolac Tromethamine

Brand: ACULAR LS · 2.6M Part D claims (CY24) · 1.6M beneficiaries · First FDA approval: 1992-12-01

21 generic mfrs 46 plans require PA Active FDA shortage

Low NADAC$0.176

→

Avg plan cost$2.09

Part D spend $54.0M 12× spread, current vs floor

Class share

100%

of class CY24 spend

View profile →

Class summary at a glance.

Every drug in this class, ranked by Part D spend.

Related questions.